Whole-transcriptome RNA sequencing and ceRNA network analyses provide novel insights into the antibacterial immune response of Hippocampus abdominalis against Vibrio harveyi
Comparative Biochemistry and Physiology Part D: Genomics and Proteomics · 2026
DOI: 10.1016/j.cbd.2026.101963 ↗Kurz gefasst
Fachartikel in der Zeitschrift Comparative Biochemistry and Physiology Part D: Genomics and Proteomics, 2026. Verfasst von Qing Chu und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Fisheries, Ludong University, Yantai, China. Electronic address: chuqing116@126.com. Hauptthemen laut MEDLINE: Vibrio, Vibrio Infections, Fish Diseases, Transcriptome. Die Arbeit nennt 46 Literaturangaben. Gefördert von: Shandong Province Natural Science Foundation, Youth Innovation Technology Project of Higher School in Shandong Province.
Abstract (Originalsprache)
Long non-coding RNAs (lncRNAs) stand as newly-arisen molecular types that exert regulatory effects, able to operate as competitive endogenous RNAs (ceRNAs) to engage microRNAs (miRNAs) in interaction, resulting in the recovery of target mRNA expression and activity. Increasing evidences indicate that the ceRNA network affects various biological processes in mammals, including development, cellular differentiation, metabolism, immune response, and disease pathogenesis. In teleost fish, the lncRNA-miRNA-mRNA regulatory networks have been reported occasionally. However, up to now, the roles of lncRNAs in the big-belly seahorse (Hippocampus abdominalis) remains unclear. In this study, we reported for the first time, via whole-transcriptome RNA sequencing, the lncRNA mediated ceRNA regulatory network in Vibrio harveyi-infected H. abdominalis. A total of 4197 differentially expressed mRNAs (DE-mRNAs), 1317 DE-lncRNAs, and 183 DE-miRNAs were identified. Furthermore, the crosstalk between miRNAs and lncRNAs as well as between miRNAs and mRNAs was inferred based on the negative correlations between miRNAs and their target lncRNAs/mRNAs. A core immune associated lncRNA-miRNA-mRNA putative regulatory network was thus constructed, comprising 211 lncRNA-miRNA and 224 mRNA-miRNA pairs. In conclusion, our findings provide an integrative overview of the ceRNA regulatory networks on the underlying immune responses to V. harveyi infection in the big-belly seahorse, and offer a solid theoretical foundation for the comparative immunological research of teleost fish.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Fisheries, Ludong University, Yantai, China. Electronic address: chuqing116@126.com.
- School of Fisheries, Ludong University, Yantai, China.
- School of Fisheries, Ludong University, Yantai, China. Electronic address: wangkyt@163.com.
Förderung
- Shandong Province Natural Science Foundation
- Youth Innovation Technology Project of Higher School in Shandong Province
Zitieren
APA
Chu, Q., Zhou, J., Bai, Y., Zhang, L., Li, M., Su, X., & Wang, K. (2026). Whole-transcriptome RNA sequencing and ceRNA network analyses provide novel insights into the antibacterial immune response of Hippocampus abdominalis against Vibrio harveyi. Comparative Biochemistry and Physiology Part D: Genomics and Proteomics. https://doi.org/10.1016/j.cbd.2026.101963
Vancouver
Chu Q, Zhou J, Bai Y, Zhang L, Li M, Su X, et al. Whole-transcriptome RNA sequencing and ceRNA network analyses provide novel insights into the antibacterial immune response of Hippocampus abdominalis against Vibrio harveyi. Comparative Biochemistry and Physiology Part D: Genomics and Proteomics. 2026. doi:10.1016/j.cbd.2026.101963
BibTeX
@article{Chu2026,
author = {Chu, Qing and Zhou, Jiale and Bai, Yuxin and Zhang, Lin and Li, Mingzhu and Su, Xiaolei and Wang, Kai},
title = {Whole-transcriptome RNA sequencing and ceRNA network analyses provide novel insights into the antibacterial immune response of Hippocampus abdominalis against Vibrio harveyi},
journal = {Comparative Biochemistry and Physiology Part D: Genomics and Proteomics},
year = {2026},
doi = {10.1016/j.cbd.2026.101963}
}
EUVIMED